mTOR-inhibitors may aggravate chronic hepatitis E

J Hepatol. 2014 Oct;61(4):720-2. doi: 10.1016/j.jhep.2014.07.016. Epub 2014 Jul 18.

Authors

Yannick Debing¹, Johan Neyts²

Affiliations

¹ Rega Institute for Medical Research, Department of Microbiology and Immunology, University of Leuven, Minderbroedersstraat 10, 3000 Leuven, Belgium.
² Rega Institute for Medical Research, Department of Microbiology and Immunology, University of Leuven, Minderbroedersstraat 10, 3000 Leuven, Belgium. Electronic address: johan.neyts@rega.kuleuven.be.

PMID: 25046849
DOI: 10.1016/j.jhep.2014.07.016

No abstract available

Keywords: 4E-BP1; Everolimus; Hepatitis E virus; Rapamycin.

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Hepatitis E virus / physiology*
Hepatitis E*
Humans
Sirolimus / analogs & derivatives*
Sirolimus / pharmacology*
TOR Serine-Threonine Kinases / immunology*

Substances

TOR Serine-Threonine Kinases
Sirolimus